[1] DENGLER T J, KATUS H A. Stem cell therapy for the infracted heart. 2002(7). doi:10.1007/s00059-002-2412-5
[2] Mitsuhiro K, WANG Y G, MAQSOOD A W. Implantation of bone marrow stem cells reduces the infarction and fibrosis in ischemic mouse heart. 2003(9). doi:10.1016/S0022-2828(3)00211-6
[3] Kocher A A. Bone marrow derived stem cells for ischemic hearts. 2003(3/4). doi:10.1007/BF03040281
[4] Al Attar N, CARRION C, GHOSTION S. Long-term (1 year) functional and histological results of autologous skeletal muscle cells transplantation in rat. 2003. doi:10.1016/S0008-6363(2)00790-3
[5] al RADI O O, RAO V, LI R K. Cardiac cell transplantation:closer to bedside, 2003(2)
[6] Rosengart T K, LEE L Y, DATEL S R. Phase Ⅰ assessment of direct intramyocardial administration of an adenovirus vector expressing VEGF121 cDNA to individuals with clinically significant severe coronary artery disease, 1999
[7] VALE P R, LOSORDO D W, MILLIIKEN C E. Left ventricular electromechanical mapping to assess efficacy of VEGF165 gene transfer for therapeutic angiogenesis in chronic myocardial ischemia, 2000
[8] Takano H, OHTSUKA M, AKAZAWA H. Pleiotropic effects of cytokines on acute myocardial infarction: G-CSF as a noval therapy for acute myocardial infarction. 2003(14). doi:10.2174/1381612033455008
[9] YANG Y, MIN J Y, RANA J S. VEGF enhances functional improvement of post imfarcted hearts by transplantation of ESC-differentiated cells. 2002
[10] Min J Y, YANG Y, SULLIVAN M F. Long-term improvement of cardiac function in rats after infarction by transplantation of embryonic stem cells. 2003(2)
[11] ALEXANDRA A, WINFRIED B, MAAZ Z. Assessment of the Tissue distribution of transplanted human endothelial progeniter cells by radioactive labeling. 2003. doi:10.1161/01.CIR.0000062649.63838.C9
[12] SHINATANI S, MUROHARA T, IKEDA H. Mobilization of endothelial progenitor cells in patients with acute myocardial infarction. 2001. doi:10.1161/hc2301.092122
[13] DARA L K, ALAN W H, ERGIN A. In vivo magnetic resonance imaging of mesenchymal stem cells in myocardial infarction. 2003. doi:10.1161/01.CIR.0000070931.62772.4E
[14] Caplice N M, GERSH B J. Stem cells to repair the heart: a clinical perspective, 2003
[15] Itescu S, KOCHER A A, SCHUSTER M D. Myocardial neovascularization by adult bone marrow-derived angioblasts:strategies for improvement of cardiomyocyte function. 2002(Z2)
[16] Brehm M, ZEUS T, STRAUER B E. Stem cells-clinical application and perspectives. 2002(7). doi:10.1007/s00059-002-2435-y
[17] DENGLER T J, KATUS H A. Stem cell therapy for the infracted heart("celluar cardiomyoplasty"). 2002(7). doi:10.1007/s00059-002-2412-5
[18] Caplice N M, GERSH B J. Stem cells to repair the heart: a clinical perspective. 2003. doi:10.1161/01.RES.0000052826.35667.40
[19] Muller E J, KEDES L H, SCHWINGER R H. Cellur cardiomyoplasty-a novel approach to treat heart disease. 2002. doi:10.1111/j.1527-5299.2002.00292.x
[20] Orlic D, HILL J, ARAI A. Stem cells for myocardial regeneration. 2002. doi:10.1161/01.RES.0000046045.00846.B0 |
